Remus Pharmaceuticals Limited — Others, 21-05-2025: Shareholders meeting

Remus Pharmaceuticals Limited has announced a postal ballot seeking shareholder approval to issue bonus shares in a 1:1 ratio, doubling its equity share capital by allotting 58.92 lakh fully paid shares. This will be funded through capitalization of reserves, retained earnings, and/or securities premium, increasing the paid-up capital to Rs. 11.78 Cr. The bonus shares will carry equal rights and will be credited directly to shareholders’ demat accounts. This step is aimed at optimizing the capital structure and rewarding shareholders.